(6R)-FR054 is a potent and selective small molecule inhibitor of PGM3, a key enzyme in the Hexosamine Biosynthetic Pathway (HBP). It demonstrates significant anti-proliferative activity against breast cancer cells in vitro and has shown efficacy in reducing tumor growth in vivo models, making it a valuable chemical probe for oncology and metabolic pathway research.